Koers Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
Aandelen
603707
CNE100002WP3
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
13,24 CNY | +0,46% | +8,70% | -11,73% |
Omzet 2023 | 3,93 mld. 543 mln. 507 mln. | Omzet 2024 * | 5,23 mld. 722 mln. 675 mln. | Marktkapitalisatie | 21,33 mld. 2,94 mld. 2,75 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -189 mln. -26,08 mln. -24,4 mln. | Nettowinst (verlies) 2024 * | 1,34 mld. 184 mln. 172 mln. | EV/omzet 2023 | 6,15 x |
Nettoliquiditeiten 2023 * | - 0 0 | Nettoliquiditeiten 2024 * | - 0 0 | EV/omzet 2024 * | 4,08 x |
K/w-verhouding 2023 |
-125
x | K/w-verhouding 2024 * |
16
x | Werknemers | 1.396 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 26,7% |
1 dag | +0,46% | ||
1 week | +8,70% | ||
Lopende maand | +18,11% | ||
1 maand | +17,58% | ||
3 maanden | -1,27% | ||
6 maanden | +11,82% | ||
Lopend jaar | -11,73% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yong Qun Tang
CEO | Chief Executive Officer | 49 | 01-01-04 |
Xiao Jie Qian
DFI | Director of Finance/CFO | 44 | 01-01-11 |
Xi Wei Huang
BRD | Director/Board Member | 54 | 01-04-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Xi Wei Huang
BRD | Director/Board Member | 54 | 01-04-11 |
Ping Shi
BRD | Director/Board Member | 62 | 16-05-19 |
Yong Qun Tang
CEO | Chief Executive Officer | 49 | 01-01-04 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.49% | 2 M€ | -16,59% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 13,24 | +0,46% | 7 840 400 |
25-04-24 | 13,18 | +2,81% | 11 665 470 |
24-04-24 | 12,82 | 0,00% | 5 736 652 |
23-04-24 | 12,82 | +0,31% | 9 597 075 |
22-04-24 | 12,78 | +4,93% | 10 988 290 |
slotkoers Shanghai S.E., 26 april 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-11,73% | 2,94 mld. | |
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |